(Q40681678)

22 September 2017

title

Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria (English)

1 reference

22 September 2017

1 reference

1 reference

Weglage J

1

1 reference

22 September 2017

Wiedermann D

2

1 reference

22 September 2017

Denecke J

3

1 reference

22 September 2017

Feldmann R

4

1 reference

22 September 2017

Koch HG

5

1 reference

22 September 2017

Ullrich K

6

1 reference

22 September 2017

Harms E

7

1 reference

22 September 2017

Möller HE

8

1 reference

22 September 2017

publication date

1 October 2001

1 reference

22 September 2017

1 reference

22 September 2017

volume

50

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

463-467

1 reference

Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997.

22 September 2017

cites work

1 reference

Different degrees of white matter abnormalities in untreated phenylketonurics: findings in magnetic resonance imaging.

21 January 2018

1 reference

Early-treated phenylketonuria: adult neuropsychologic outcome.

21 January 2018

1 reference

In vivo NMR spectroscopy in patients with phenylketonuria: clinical significance of interindividual differences in brain phenylalanine concentrations.

21 January 2018

1 reference

Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls.

21 January 2018

1 reference

Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.

21 January 2018

1 reference

Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo.

21 January 2018

1 reference

The effects of high phenylalanine concentrations on serotinin and catecholamine metabolism in the human brain

21 January 2018

1 reference

White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.

21 January 2018

1 reference

Blood-brain phenylalanine relationships in persons with phenylketonuria

21 January 2018

1 reference

Intelligence and quality of dietary treatment in phenylketonuria

21 January 2018

1 reference

Magnetic resonance imaging of the brain in phenylketonuria

21 January 2018

1 reference

Synaptic density in human frontal cortex — Developmental changes and effects of aging

21 January 2018

1 reference

Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria

21 January 2018

1 reference

Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria

21 January 2018

1 reference

EEGs in phenylketonuria. I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs and cognitive function.

21 January 2018

1 reference

Genotype and Intellectual Phenotype in Untreated Phenylketonuria Patients

21 January 2018

1 reference

In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment

21 January 2018

1 reference

Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria

21 January 2018

1 reference

Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria

21 January 2018

1 reference

The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic resonance spectroscopy

21 January 2018

1 reference

Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.1226

1 reference

22 September 2017

1 reference